Over the last several years, a number of important changes have occurred in the mental health care of children and adolescents in the United States.
1-3 Perhaps most importantly, there has been an increased clinical emphasis on pharmacological management.
4 This emphasis has been supported by large randomized controlled trials of stimulants for attention-deficit/hyperactivity disorder (ADHD),
5 antipsychotics for bipolar mania
6 and behavioral problems associated with autism,
7 and antidepressants for major depressive disorder
8 and several anxiety disorders.
9 Advances in pharmacological management, alongside development of evidence-based psychotherapies for common child and adolescent psychiatric disorders,
10 have been incorporated into disorder-specific clinical practice guidelines.
11-14